Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Anika Therapeutics, Inc.
WARNING LETTER
•Anika Therapeutics, Inc.•March 21, 2008

Anika Therapeutics, Inc. – FDA Warning Letter, Mar 21, 2008

Record Details

On July 2, 2008, the FDA issued a Warning Letter to Anika Therapeutics, Inc. following a March 10-21, 2008 inspection of their Woburn, MA facility. The inspection revealed that the firm's medical devices (Amvisc, Amvisc Plus, Staarvisc II, Shellgel, Orthovisc) were adulterated under 21 U.S.C. § 351(h) due to non-conformity with Quality System (QS) regulations (21 C.F.R. Part 820). The animal drug Hyvisc was also found adulterated under 21 U.S.C. § 351(a)(2)(B) for failing to meet cGMP regulations (21 C.F.R. Part 211).

Key violations included: 1. **Inadequate Quality System (21 C.F.R. § 820.20):** Management failed to ensure an effective quality system, evidenced by the quality department not observing critical manufacturing steps, lack of environmental monitoring, and absence of a required handwashing sink outside the sterile gowning room. 2. **Process Validation Failures (21 C.F.R. § 820.75(a)):** Media fills did not fully simulate routine aseptic manufacturing, critical area

Company
Anika Therapeutics, Inc.
Inspection date
March 21, 2008
Product type
Devices
Office
New England District Office
Person
  • Michael R. Kravchuk (Retired Director)
View Company Profile

ID · 87a7b3fb-1294-40d6-b531-30e69ad8899c

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 321(g)(1)(B)21 U.S.C. 351(h)21 CFR 82021 CFR 820.2021 CFR 820.75(a)21 CFR 820.100(a)(2)21 CFR 820.70(a)21 CFR 820.19821 CFR 820.70(e)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Anika Therapeutics, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.